Ferring Pharmaceuticals and Gallup Announce Landmark Global Public Attitudes Study on Fertility and Family-Building

Contributed by: Business Wire

Logo

Tags

Women

Baby/Maternity

Men

Public Policy/Government

Family

Health

Consumer

Pharmaceutical

Public Policy

Ferring Pharmaceuticals

More Like This

With Two in Five Employees Undergoing Fertility Treatment Leaving Their Jobs or Considering Quitting, Are Companies Doing Enough?

For the First Time, Ferring Reports Revenue of Over €2.5 Billion in 2025

Launch of two first-in-class medicines in 2023 marks start of exciting phase of growth for Ferring

PR Newswire associated0

The FII Institute Announces Findings of 2024 FII PRIORITY Compass

PR Newswire associated0

GLOBAL SURVEY IDENTIFIES COST OF LIVING, LONELINESS, TECHNOLOGY, CLIMATE CONCERNS DEEPENING

Dr James Liang Launches HK$500 Million "Genovation Foundation" to Address Low Fertility

Ferring achieved record sales driven by Reproductive Medicine combined with the emergence of Adstiladrin

Hologic Global Women's Health Index Fifth Edition

1.5 Billion Women Miss Essential Preventive Tests, Despite Uptick in Global Screening Rates